Cargando…

Reduced Serum Butyrylcholinesterase Activity Indicates Severe Systemic Inflammation in Critically Ill Patients

Systemic inflammation is an immune response to a nonspecific insult of either infectious or noninfectious origin and remains a challenge in the intensive care units with high mortality rate. Cholinergic neurotransmission plays an important role in the regulation of the immune response during inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zivkovic, Aleksandar R., Schmidt, Karsten, Sigl, Annette, Decker, Sebastian O., Brenner, Thorsten, Hofer, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339712/ https://www.ncbi.nlm.nih.gov/pubmed/25762852 http://dx.doi.org/10.1155/2015/274607

Ejemplares similares

Reduced butyrylcholinesterase activity is an early indicator of trauma-induced acute systemic inflammatory response
por: Zivkovic, Aleksandar R, et al.
Publicado: (2016)

A Sustained Reduction in Serum Cholinesterase Enzyme Activity Predicts Patient Outcome following Sepsis
por: Zivkovic, Aleksandar R., et al.
Publicado: (2018)

Critically Ill COVID-19 Patients Show Reduced Point of Care-Measured Butyrylcholinesterase Activity—A Prospective, Monocentric Observational Study
por: Espeter, Florian, et al.
Publicado: (2022)

Increased Enzymatic Activity of Acetylcholinesterase Indicates the Severity of the Sterile Inflammation and Predicts Patient Outcome following Traumatic Injury
por: Zivkovic, Aleksandar R., et al.
Publicado: (2023)

Serum cholinesterase activity as an early indicator of systemic inflammation
por: Zivkovic, AR, et al.
Publicado: (2015)

Non-Neuronal Acetylcholinesterase Activity Shows Limited Utility for Early Detection of Sepsis
por: Zivkovic, Aleksandar R., et al.
Publicado: (2023)

Bedside-measurement of serum cholinesterase activity predicts patient morbidity and length of the intensive care unit stay following major traumatic injury
por: Zivkovic, Aleksandar R., et al.
Publicado: (2019)

Concurrent Change in Serum Cholinesterase Activity and Midregional-Proadrennomedullin Level Could Predict Patient Outcome following Liver Transplantation
por: Decker, Sebastian O., et al.
Publicado: (2022)

Immune-Response Patterns and Next Generation Sequencing Diagnostics for the Detection of Mycoses in Patients with Septic Shock—Results of a Combined Clinical and Experimental Investigation
por: Decker, Sebastian O., et al.
Publicado: (2017)

Cytidine-5-diphosphocholine reduces microvascular permeability during experimental endotoxemia
por: Schmidt, Karsten, et al.
Publicado: (2015)

Butyrylcholinesterase–Protein Interactions in Human Serum
por: Jasiecki, Jacek, et al.
Publicado: (2021)

Response to: Comment on “A Sustained Reduction in Serum Cholinesterase Enzyme Activity Predicts Patient Outcome following Sepsis”
por: Zivkovic, Aleksandar R., et al.
Publicado: (2019)

Plasma cholinesterase activity as diagnostic marker for systemic inflammation
por: Zivkovic, AR, et al.
Publicado: (2014)

Data on microcirculatory parameters of GTS- 21 treated rats assessed by intravital microscopy
por: Schmidt, Karsten, et al.
Publicado: (2017)

Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity
por: Zivkovic, Aleksandar R., et al.
Publicado: (2015)

Characteristics of Critically Ill Patients with COVID-19 Compared to Patients with Influenza—A Single Center Experience
por: Herbstreit, Frank, et al.
Publicado: (2021)

Acetylcholinesterase and butyrylcholinesterase in cardiosurgical patients with postoperative delirium
por: John, Mira, et al.
Publicado: (2017)

Reduced butyrylcholinesterase activity is an early indicator of trauma-induced acute systemic inflammatory response [Corrigendum]
Publicado: (2017)

Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka Oryzias latipes
por: Pezzementi, Leo, et al.
Publicado: (2011)

Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation
por: Reale, Marcella, et al.
Publicado: (2018)

Serum Butyrylcholinesterase Activity: A Biomarker for Parkinson's Disease and Related Dementia
por: Dong, Mei-Xue, et al.
Publicado: (2017)

Correction: Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka Oryzias latipes
por: Pezzementi, Leo, et al.
Publicado: (2011)

Molecular forms of butyrylcholinesterase and obesity
por: Boberg, Dellyana R., et al.
Publicado: (2010)

Caffeine Inhibits Acetylcholinesterase, But Not Butyrylcholinesterase
por: Pohanka, Miroslav, et al.
Publicado: (2013)

Electrochemical MIP Sensor for Butyrylcholinesterase
por: Ozcelikay, Goksu, et al.
Publicado: (2019)

Identification of Compounds for Butyrylcholinesterase Inhibition
por: Li, Shuaizhang, et al.
Publicado: (2021)

Substantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albumin
por: Huang, Yue-Jin, et al.
Publicado: (2008)

Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach
por: Sridhar, GR, et al.
Publicado: (2005)

Serum butyrylcholinesterase predicts survival after extracorporeal membrane oxygenation after cardiovascular surgery
por: Distelmaier, Klaus, et al.
Publicado: (2014)

Influence of obstructive sleep apnea on serum butyrylcholinesterase activity and ischemia-modified albumin levels
por: Yang, Liu-Xue, et al.
Publicado: (2013)

New Insights into Butyrylcholinesterase Activity Assay: Serum Dilution Factor as a Crucial Parameter
por: Jońca, Joanna, et al.
Publicado: (2015)

Time-dependent effects of storage at –80 °C on the stability of butyrylcholinesterase activity in human serum
por: Huang, Chien-Hui, et al.
Publicado: (2022)

Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer
por: Gentzsch, Christian, et al.
Publicado: (2021)

Probing the Peripheral Site of Human Butyrylcholinesterase
por: Macdonald, Ian R., et al.
Publicado: (2012)

Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity
por: Pohanka, Miroslav
Publicado: (2014)

Serum soluble-Fas, inflammation and anemia in acute renal failure and critical illness
por: Góes, MA, et al.
Publicado: (2011)

Relationship between reduced albumin and inflammation in the critically ill
por: Marano, Marco
Publicado: (2015)

Bedside Hyperspectral Imaging and Organ Dysfunction Severity in Critically Ill COVID-19 Patients—A Prospective, Monocentric Observational Study
por: Kuhlmann, Henning, et al.
Publicado: (2023)

Synthesis and Initial Characterization of a Reversible, Selective (18)F-Labeled Radiotracer for Human Butyrylcholinesterase
por: Gentzsch, Christian, et al.
Publicado: (2021)

Quality indicators in critically ill patients
por: Martin, M, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_f87cf4a60a2ep2bbhbjh053gii